May 05, 2026
A Delaware federal judge on Friday dismissed a proposed class action brought by Chemours investors alleging that the chemical company's executives manipulated financial metrics for personal gain, saying the plaintiffs didn't show the existence of a material misrepresentation.
March 21, 2024
Chemical company The Chemours Co. and four of its current and former executives face claims they hurt investors by manipulating a certain financial metric so the executives might receive greater compensation under the company's incentive plans.